(Q45785162)

16 December 2017

title

Protection of SJL/J mice from demyelinating disease mediated by Theiler's murine encephalomyelitis virus (English)

1 reference

16 December 2017

main subject

demyelinating disease

1 reference

Kurtz CI

1 reference

16 December 2017

Sun XM

series ordinal

1 reference

16 December 2017

Fujinami RS

series ordinal

1 reference

16 December 2017

publication date

1 January 1995

1 reference

16 December 2017

published in

Microbial Pathogenesis

1 reference

16 December 2017

volume

1 reference

16 December 2017

issue

1 reference

16 December 2017

page(s)

11-27

1 reference

16 December 2017

SPONTANEOUS ENCEPHALOMYELITIS OF MICE, A NEW VIRUS DISEASE

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Pathogenesis of Theiler's murine encephalomyelitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Demyelinative myelopathy in mice induced by the DA virus

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Theiler's virus antigen detected in mouse spinal cord 21/2 years after infection

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Theiler's Virus-Induced Demyelination: Prevention by Immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Immunization of chimpanzees and human beings with avirulent strains of poliomyelitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Properties and behavior of orally administered attenuated poliovirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Effect of immunization with Theiler's virus on the course of demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Mouse myelomas and lymphomas in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens*

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Infectious hepatitis. Studies on the effect of gamma globulin and on the incidence of inapparent infection

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Clearance of lymphocytic choriomeningitis virus in antibody- and B-cell-deprived mice

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Theiler's virus infection of beta 2-microglobulin-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

An isoelectric focusing overlay study of the humoral immune response in Theiler's virus demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Central Nervous System Immunity in Mice Infected with Theiler's Virus. I. Local Neutralizing Antibody Response

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Protection against experimental autoimmune encephalomyelitis requires both CD4+ T suppressor cells and myelin basic protein-primed B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

The ELISA-plaque assay for the detection and enumeration of antibody-secreting cells. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV).

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

Isolation of brain parenchymal lymphocytes for flow cytometric analysis. Application to acute viral encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0882-4010%2805%2980009-9

7 January 2021

10.1016/S0882-4010(05)80009-9

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017